Bioventus Inc. (BVS) vs Integra LifeSciences Holdings Corporation (IART)
- Bioventus Inc. BVS 13.30 −3.69%
- Integra LifeSciences Holdings Corporation IART 13.21 −2.37%
Bioventus Inc. and Integra LifeSciences Holdings Corporation are both Medical Devices companies. Bioventus Inc. is the larger, with a market value of $1.2B against $1.1B — 1.1× the size. Integra LifeSciences Holdings Corporation has negative trailing earnings, so its P/E is not meaningful; Bioventus Inc. trades at 16.4×. Bioventus Inc. grew revenue faster over the last twelve months: 3.14% against 1.60%. Bioventus Inc. has the higher net margin (9.36% vs −0.44%) and the higher return on invested capital (7.34% vs 1.58%). Across the 21 metrics below, Bioventus Inc. leads on 16 and Integra LifeSciences Holdings Corporation on 5.
Valuation
Profitability
| Metric | BVS | IART | Medical Devices median |
|---|---|---|---|
| Gross margin | 68.65% | 52.47% | 56.01% |
| Operating margin | 10.02% | 3.98% | (15.03%) |
| Net margin | 9.36% | (0.44%) | (20.40%) |
| Free cash flow margin | 16.20% | 1.57% | (7.24%) |
| Return on equity | 22.75% | (0.70%) | (15.32%) |
| Return on assets | 7.89% | (0.20%) | (19.72%) |
| Return on invested capital | 7.34% | 1.58% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack